ETH Zurich spin-off Alivion has secured CHF 3.8 million in funding to develop and test its next breath analysis device in patients. The funding comprises a capital increase and a non-dilutive grant …
Read Full Story at source (may require registration)
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024